Clinical Trials in San Francisco

Showing 7861-7880 of 9,883 trials

IOK Treatment Study

NCT01605799

The goals of this project are * 1\) to evaluate the effectiveness of a CBT treatment module addressing the mental health and functional impact of killing in the war zone, * 2\) to gather data on Veteran stakeholders' perceptions of acceptability and feasibility of the CBT treatment module, which would be used to further refine the intervention, and * 3\) to gather data on clinician stakeholders' perceptions of acceptability and feasibility of the CBT treatment module, which would be used to ensure that the module could be easily integrated into EBT for PTSD.

Posttraumatic Stress Disorder

VA Office of Research and Development33 participantsStarted Oct 2012

San Francisco, California, United States

COMPLETEDPhase 4< 1 mile

ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.

NCT00077636

This study will evaluate the efficacy and safety of different durations of treatment with PEGASYS combined with ribavirin in patients with CHC genotype 2 or 3 infection who have never previously received interferon (IFN) therapy. The anticipated time on study treatment is 3-12 months and the target sample size is 500+ individuals.

Hepatitis C, Chronic

Hoffmann-La Roche1,469 participantsStarted Dec 2003

Birmingham, Alabama, United States • Mobile, Alabama, United States • Anchorage, Alaska, United States +129 more locations

IOK Treatment Study

ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.

Find Trials by Condition in San Francisco

Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 Days

GORE Flow Reversal System and GORE Embolic Filter Extension Study

Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2

Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis

Blood Neurotrophic Factors in Adults

The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine

Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Children

A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer

A Comparative RCT of Brief Internet-based Compassionate Mind Training and Cognitive-behavioral Therapy for Mothers and Their Babies

Blood and Marrow Transplant Clinical Research Network

Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA

Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus

Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

Relapse Prevention Study in Newly Abstinent Smokers

First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma

Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)

Atacicept in Subjects With Optic Neuritis